Mu-Yan Cai (Muyan Cai)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 30

Top Venues

Nature medicine

Nature communications

Cancer communications (London, England)

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xin-Ke Zhang, Zihan Zhao, Ruixuan Wang, Haohua Chen, Xueyi Zheng, Lili Liu, Lilong Lan, Peng Li, Shuyang Wu, Qinghua Cao, Rongzhen Luo, Wan-Ming Hu, Shanshan Lyu, Zhengyu Zhang, Dan Xie, Ya-Ping Ye, Yu Wang, Mu-Yan Cai
A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma. Nature communications 15 (1) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Xin-Ke Zhang, Zihan Zhao, Ruixuan Wang, Haohua Chen, Xueyi Zheng, Lili Liu, Lilong Lan, Peng Li, Shuyang Wu, Qinghua Cao, Rongzhen Luo, Wan-Ming Hu, Shanshan Lyu, Zhengyu Zhang, Dan Xie, Ya-Ping Ye, Yu Wang, Mu-Yan Cai
A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma. Nature communications 15 (1) (2024)
Xin-Ke Zhang, Zihan Zhao, Ruixuan Wang, Haohua Chen, Xueyi Zheng, Lili Liu, Lilong Lan, Peng Li, Shuyang Wu, Qinghua Cao, Rongzhen Luo, Wan-Ming Hu, Shanshan Lyu, Zhengyu Zhang, Dan Xie, Ya-Ping Ye, Yu Wang, Mu-Yan Cai
A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma. Nature communications 15 (1) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Yang Liu, Shuang-Yan Ye, Shuai He, Dong-Mei Chi, Xiu-Zhi Wang, Yue-Feng Wen, Dong Ma, Run-Cong Nie, Pu Xiang, You Zhou, Zhao-Hui Ruan, Rou-Jun Peng, Chun-Ling Luo, Pan-Pan Wei, Guo-Wang Lin, Jian Zheng, Qian Cui, Mu-Yan Cai, Jing-Ping Yun, Junchao Dong, Hai-Qiang Mai, Xiaojun Xia, Jin-Xin Bei
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma. Nature communications 15 (1) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
You-Cheng Zhang, Tian-Chen Zhu, Run-Cong Nie, Liang-He Lu, Zhi-Cheng Xiang, Dan Xie, Rong-Zhen Luo, Mu-Yan Cai
Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors. Journal of clinical medicine 12 (3) (2023)
Jie Zhou, Run-Cong Nie, Zhang-Ping He, Xiao-Xia Cai, Jie-Wei Chen, Wen-Ping Lin, Yi-Xin Yin, Zhi-Cheng Xiang, Tian-Chen Zhu, Juan-Juan Xie, You-Cheng Zhang, Xin Wang, Peng Lin, Dan Xie, Alan D D'Andrea, Mu-Yan Cai
STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
You-Cheng Zhang, Tian-Chen Zhu, Run-Cong Nie, Liang-He Lu, Zhi-Cheng Xiang, Dan Xie, Rong-Zhen Luo, Mu-Yan Cai
Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors. Journal of clinical medicine 12 (3) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) 44 (1) (2023)
You-Cheng Zhang, Tian-Chen Zhu, Run-Cong Nie, Liang-He Lu, Zhi-Cheng Xiang, Dan Xie, Rong-Zhen Luo, Mu-Yan Cai
Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors. Journal of clinical medicine 12 (3) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) 44 (1) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) 44 (1) (2023)
Yi-Hong Ling, Meng-Ni Liu, Yi-Xin Yin, Zhong-Guo Zhou, Jie-Wei Chen, Wei Wei, Jing-Ping Yun, Dan Xie, Rong-Ping Guo, Mu-Yan Cai
Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Jie Zhou, Run-Cong Nie, Yi-Xin Yin, Xiao-Xia Cai, Dan Xie, Mu-Yan Cai
Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity. Disease markers 2022 (2022)
Xin-Ke Zhang, Suijing Wang, Run-Cong Nie, Chunhua Qu, Jierong Chen, Yuanzhong Yang, Mu-Yan Cai
Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy. Cancers 14 (3) (2022)
Xueyi Zheng, Yuhua Huang, Kai Li, Rongzhen Luo, Mu-Yan Cai, Jingping Yun
Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies. Viruses 14 (5) (2022)
Xueyi Zheng, Ruixuan Wang, Xinke Zhang, Yan Sun, Haohuan Zhang, Zihan Zhao, Yuanhang Zheng, Jing Luo, Jiangyu Zhang, Hongmei Wu, Dan Huang, Wenbiao Zhu, Jianning Chen, Qinghua Cao, Hong Zeng, Rongzhen Luo, Peng Li, Lilong Lan, Jing-Ping Yun, Dan Xie, Wei-Shi Zheng, Junghang Luo, Mu-Yan Cai
A deep learning model and human-machine fusion for prediction of EBV-associated gastric cancer from histopathology. Nature communications 13 (1) (2022)
Jin-Ling Duan, Wei Chen, Juan-Juan Xie, Mao-Lei Zhang, Run-Cong Nie, Hu Liang, Jie Mei, Kai Han, Zhi-Cheng Xiang, Feng-Wei Wang, Kai Teng, Ri-Xin Chen, Min-Hua Deng, Yi-Xin Yin, Nu Zhang, Dan Xie, Mu-Yan Cai
A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Molecular cancer 21 (1) (2022)
Li-Li Wang, Jie Luo, Zhang-Hai He, Ye-Qing Liu, Hai-Gang Li, Mu-Yan Cai, Mu-Yan Cai
STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma. Cell death & disease 12 (11) (2021)

Mu-Yan Cai.css-eqlu8i{font-size:small;padding-left:4px;} (Muyan Cai)

Publication Activity (10 Years)

Top Topics

Top Venues

Mu-Yan Cai (Muyan Cai)